BioResource International, Inc. Names New Chief Commercial Officer

Durham, North Carolina (April 01, 2021) – BioResource International (BRI) announced Flemming Mahs will join their executive leadership team in the role of Chief Commercial Officer, with a focus on portfolio commercialization. “BRI understands the importance of having a customer-centric go to market strategy. We are excited to have Flemming on board to help us deliver on…

Details

Response to COVID-19

In anticipation of the global impact of novel Coronavirus (COVID-19) to the feed industry, BioResource International, Inc. (BRI) has taken measures to ensure the safety of our employees and to continue production of our products. BRI has taken the following actions: Implemented a policy of working remotely when and where possible to reduce the risks.…

Details

BioResource International, Inc. Research Partners to Present the Effects of Combinational Use of Xylanase and Direct-fed Microbials in Nursery Pig Diets at the 2020 ASAS-Midwest Meeting

Research Triangle Park, N.C. — February 9, 2020 —BioResource International, Inc. (BRI), a global biotechnology company specializing in the research, development, and manufacture of high-performance enzyme and probiotic feed additives for optimizing animal nutrition and gut health, announced today that findings from a comprehensive study using its xylanase-direct-fed microbial feed additive, EnzaPro®, in nursery pig…

Details

BioResource International, Inc. to present the effects of EnzaPro®, a novel zymbiotic feed additive, on Tilapia performance and nutrient digestibility at Aquaculture America 2020

Research Triangle Park, N.C. — February 9, 2020 —BioResource International, Inc. (BRI), a global biotechnology company specializing in the research, development and manufacture of high-performance enzyme and probiotic feed additives for optimizing animal nutrition and gut health, announced today that findings from a comprehensive study using its xylanase-direct-fed microbial feed additive, EnzaPro®, in Nile Tilapia…

Details

BioResource International, Inc. to use Gene Editing Technology to Drive Innovation in Animal Health and Nutrition

Research Triangle Park, N.C. – BioResource International, Inc. (BRI), a global biotechnology company specializing in the research, development and manufacture of high-performance enzyme feed additives for optimizing animal nutrition and gut health, has licensed gene editing technology from The Broad Institute and Pioneer Hi-Bred International.  CRISPR (Clustered, Regularly Interspaced Short Palindromic Repeats) paired with the…

Details